Vericel Cash Flow Statement
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
40.10+0.05 (+0.12%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vericel free cash flow
In fiscal 2025, Vericel generated $51.9 million of operating cash flow and spent $27.2 million on capital expenditures. That left free cash flow of $24.7 million, a free-cash-flow margin of 9.0% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Vericel cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 16.52M | 10.36M | -3.18M | -16.71M | -7.47M | 2.86M | -9.66M | -8.14M | -17.29M | -19.57M |
| Net Income growth (YoY) | +59.41% | — | — | — | -360.86% | — | — | — | — | — |
| Depreciation & Amortization | 11.54M | 5.50M | 4.63M | 3.98M | 2.96M | 2.38M | 1.70M | 1.43M | 1.61M | 1.89M |
| Stock-Based Compensation | 38.77M | 36.49M | 32.33M | 37.18M | 34.32M | 13.84M | 13.18M | 7.22M | 2.68M | 2.50M |
| Change in Working Capital | -20.45M | -7.39M | -5.77M | -10.27M | -5.47M | -4.83M | -13.06M | -4.26M | -2.02M | -9.14M |
| Operating Cash Flow | 51.91M | 58.16M | 35.31M | 17.69M | 29.04M | 17.57M | -7.18M | -412.00K | -13.18M | -19.89M |
| Capital Expenditures | -27.16M | -63.97M | -20.01M | -7.60M | -7.92M | -2.63M | -2.62M | -2.68M | -1.51M | -1.42M |
| Investing Cash Flow | -43.94M | -79.03M | -3.13M | -36.21M | -3.50M | -17.16M | 10.62M | -67.03M | -1.51M | -1.42M |
| Debt Repaid | — | — | — | — | — | 0 | 0 | -17.53M | -7.15M | -38.00K |
| Financing Cash Flow | 7.07M | 19.05M | 3.62M | 1.04M | 9.17M | 6.44M | 5.26M | 58.86M | 18.58M | 29.70M |
| Net Change in Cash | 15.04M | -1.82M | 35.80M | -17.47M | 34.71M | 6.85M | 8.69M | -8.58M | 3.88M | — |
| Free Cash Flow | 24.75M | -5.81M | 15.30M | 10.09M | 21.13M | 14.95M | -9.80M | -3.09M | -14.69M | -21.31M |
This table shows 10 annual periods of Vericel's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow VCEL's reporting calendar. What is a cash flow statement?